Oncology.

Collaborating with clients to advance life-saving oncology treatments.

Scroll

Helping to shape the future of oncology treatments.

Over 30 years of experience and our position at the forefront of therapeutic advancements promise expertise and agility at every stage of your product lifecycle. We combine innovative strategy with medical and scientific expertise, and real-world data with human empathy. Our vision, like yours, is to advance cancer medicines, improve patient outcomes and get the right treatments to the right patients, faster.

On-demand webinar: Are we ready for the next era of cancer care?

Watch our latest webinar on-demand to discover the future of cancer treatment and how patient-centered approaches can revolutionize the way we care for those affected by this disease.

Watch now

Oncology expertise.*

We lead the way in advancing oncology treatments by partnering closely with our clients, combining unparalleled expertise with a dynamic approach to every facet of this fast-paced therapy area.

*Based on company revenue data 2022-2023 & external sources (Evaluate Pharma).

of oncology product launches in the last two years have been supported by Inizio.

of the top 20 oncology products are being developed in partnership with Inizio right now.

assets were supported in the pivotal clinical trial stage by Inizio in 2023.

We have collaborated on 100% of the top 20 oncology products in the last 2 years, working on 148 oncology assets with 91 of these being small molecule oncology assets.

Why choose us as your trusted oncology partner?

Harness unparalleled expertise: Our scientific and medical knowledge, connected approach and deep understanding of the oncology market has been established over 30 years.

Develop actionable insights: Our approach is underpinned by technology, the latest medical and scientific oncology data and HCP and patient insights, that results in actionable insights for your product.

Combining innovative strategy with agile approach: By collaborating across multiple teams, trials and disciplines, we generate agile, innovative strategies to meet oncology trends, expedite clinical journeys and navigate your successful product launch.

Improve patient outcomes: At the heart of everything is the patient. Together, we focus on developing oncology solutions that bridge the product lifecycle with the complexities and emotions of the patient journey.

Key findings and missed gems from ASCO 2024.

Discover the most talked-about topics in the oncology landscape at present, including in-depth analysis, key takeaways and gems you might have missed at the 2024 ASCO® Annual Meeting.

Watch the on-demand webinar

Maintaining agility in oncology trends.

In a fast-changing therapy area, explore the current oncology insights.

Supporting a new European division to launch brands in eight markets

Supporting a new European division to launch brands in eight markets.

Clinical Educator Oncology Program Improves Adherence by 29%

Client’s specialty product had a complicated oral therapy regimen requiring supplemental support to patients...

Virtual Oncology MSL Team Increases KOL Engagement by 120%

CASE STUDY (US) Virtual Oncology MSL team increases KOL engagement by 120%, exceeds insights gained goal by 600%.

Opportunities and challenges from the rise of antibody drug coagulates

Antibody drug coagulates (ADCs) are an inherently complex, fast-moving field of oncology.

Your market-leading commercialization partner.

Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.

Speak to one of our team